酪氨酸激酶抑制剂AG 1478

AG-1478 (Tyrphostin AG-1478) (订货以英文为准)

编号:A126582
CAS号:153436-53-4
分子式:C16H14CLN3O2
分子量:315.75
货号 品牌 包装 目录价 您的价格 库存 数量 购买
A126582-10mg 阿拉丁 10mg ¥556.90
A126582-25mg 阿拉丁 25mg ¥1235.90
A126582-5mg 阿拉丁 5mg ¥411.90
A126582-50mg 阿拉丁 50mg ¥1528.90
产品名称 AG-1478 (Tyrphostin AG-1478)
中文名称 酪氨酸激酶抑制剂AG 1478
CAS号 153436-53-4
分子式(M.F.) C16H14CLN3O2
分子量(M.W.) 315.75
储存条件 -20°C储存
溶解性25°C: DMSO 25 mg/mL; Water <1 mg/mL; Ethanol 13 mg/mL
存贮条件储存温度-20°C
密度1.3370
产品介绍AG-1478 (NSC 693255)是高效EGFR选择性抑制剂,IC50为3 nM,对HER2-Neu,PDGFR,Trk,Bcr-Abl和InsR无活性。
备注AG-1478 (Tyrphostin AG-1478) is a selective EGFR inhibitor with IC50 of 3 nM, almost no activity on HER2-Neu, PDGFR, Trk, Bcr-Abl and InsR.
生化机理AG1478 inhibited EGFR phosphorylation in CNE2 cells without reduced expression of EGFR protein. The activation of Akt and MAPK which are downstream molecules of EGFR signaling pathway, were also inhibited by AG1478 . Although AG 1478 inhibited cell growth, DNA synthesis, EGFR tyrosine kinase activity, and receptor autophosphorylation of each cell line in a dose-dependent manner, it was significantly more potent in U87MG. delta EGFR cells than in the other two cell lines .in vivo: At the lowest dose, plasma drug levels after the cessation of infusion declined with a half-life of approximately 43 min. EGFR activity, measured both by autophosphorylation and downstream signalling, was inhibited in a dose-dependent manner by injection of AG1478 in mice bearing xenografts of the human glioblastoma cell line U87MG
别名酪氨酸激酶抑制剂AG 1478; N-(3-氯苯基)-6,7-二甲氧基-4-氨基喹唑啉;(3-氯苯基)(6,7-二甲氧基喹唑啉-4-基)胺;Tyrphostin AG-1478;AG 1478;NSC 693255;AG1478;N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine;3-chlorophenyl)(6,7-dimethoxyquinazolin-4-yl)amine
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:130-22-3
¥ 98.00 A835626-100ml
CAS号:2243-76-7
¥ 78.00 A835612-100ml
CAS号:23103-98-2
¥ 90.00 P816121-1ml
CAS号:1398-61-4
¥ 749.00 C805623-250mg
CAS号:75-27-4
¥ 185.00 B801896-2ml
CAS号:75-27-4
¥ 190.00 B801895-2ml
¥ 500.00 sh6786-10mL
¥ 420.00 01484972-4L
¥ 259.00 sh24567-1个